Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.04 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Matthew M. Loar

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 6 different industries.

52--

Background*

Mr. Matthew M. Loar, also known as Matt, has been Chief Financial Officer of OXiGENE, Inc. since July 2015. Mr. Loar served as Chief Financial Officer of KineMed, Inc. from January 2014 to July 2015. From January 2010 to January 2014, Mr. Loar was an independent financial consultant to companies in the biopharmaceutical industry. He served as an Acting Chief Executive Officer and Acting Chief Financial Officer of Neurobiological Technologies Inc. since February 2010 ...

Read Full Background

Corporate Headquarters*

2000 Powell Street
Emeryville, California 94608

United States

Phone: 510-595-6000
Fax: 510-595-6006

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
University of California Berkeley

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NTII:US $0.04 USD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEUROBIOLOGICAL TECHNOLOGIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.